Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone in Hemodialysis Patients
NCT00548912Phase 4Withdrawn
- Start
- Oct 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of spironolactone in left ventricular hypertrophy (LVH). Planned start Oct 2007; status: withdrawn.
02
Drugs
spironolactone
03
Conditions
left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on NCT00548912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00548912.